In the last 20 years, only two new drugs have been approved that were specifically developed to treat children with cancer. Now there are three. On March 10, 2015 the FDA approved this new drug to treat high-risk neuroblastoma, making it available not only through a clinical trial, but for all kids with this aggressive childhood cancer. Read more about this amazing breakthrough:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm437460.htm